CLINICAL OUTCOME AND PROGNOSIS IN 49 PATIENTS WITH MANTLE CELL LYMPHOMA TREATED WITH ROUTINE CLINICAL PRACTICE

被引：0
|
作者：
Tumyan, G. [1 ]
Zeynalova, P. [1 ]
Falaleeva, N. [1 ]
Ilyasova, I. [1 ]
Larionova, V. [1 ]
Osmanov, E. [1 ]
机构：
[1] NN Blokhin Russian Canc Res Ctr, Moscow, Russia
来源：
HAEMATOLOGICA | 2016年 / 101卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PB1745
引用
收藏
页码：708 / 709
页数：2
相关论文
共 50 条
  • [21] Profile of patients treated with omalizumab in routine clinical practice in Spain
    Ancochea, J.
    Chivato, T.
    Casan, P.
    Picado, C.
    Herraez, L.
    Casafont, J.
    ALLERGOLOGIA ET IMMUNOPATHOLOGIA, 2014, 42 (02) : 102 - 108
  • [22] CLINICAL OUTCOMES OF PATIENTS WITH GIANT CELL ARTERITIS AND POLYMYALGIA RHEUMATICA SYMPTOMS TREATED WITH TOCILIZUMAB IN ROUTINE CLINICAL PRACTICE
    Unizony, Sebastian
    Spiera, Robert
    Pei, Jinglan
    Sidiropoulos, Paris
    Best, Jennie H.
    Stone, John H.
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 440 - 440
  • [23] Clinical Outcomes of Patients with Giant Cell Arteritis and Polymyalgia Rheumatica Symptoms Treated with Tocilizumab in Routine Clinical Practice
    Unizony, Sebastian
    Spiera, Robert
    Pei, Jinglan
    Sidiropoulos, Paris
    Best, Jennie
    Stone, John
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [24] IBRORS-MCL study: a Spanish retrospective and observational study of relapsed/refractory mantle-cell lymphoma treated with ibrutinib in routine clinical practice
    Sancho, Juan-Manuel
    Marin-Niebla, Ana
    Fernandez, Silvia
    Capote, Francisco-Javier
    Canigral, Carolina
    Grande, Carlos
    Donato, Eva
    Zeberio, Izaskun
    Puerta, Jose-Manuel
    Rivas, Alfredo
    Perez-Ceballos, Elena
    Vale, Ana
    Martin Garcia-Sancho, Alejandro
    Salar, Antonio
    Gonzalez-Barca, Eva
    Teruel, Anabel
    Pastoriza, Carmen
    Conde-Royo, Diego
    Sanchez-Garcia, Joaquin
    Barrenetxea, Cristina
    Arranz, Reyes
    Hernandez-Rivas, Jose-Angel
    Ramirez, Maria-Jose
    Jimenez, Aroa
    Rubio-Azpeitia, Eva
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2022, 116 (03) : 381 - 392
  • [25] Evaluation of safety, tolerability and efficacy of temsirolimus in patients (pts) with relapsed or refractory mantle cell lymphoma (rel/refr MCL) in routine clinical practice
    Dreyling, M. H.
    Hess, G.
    Woike, M.
    Krekeler, G.
    ANNALS OF ONCOLOGY, 2018, 29 : 362 - 362
  • [26] Evaluation of safety, tolerability and efficacy of Temsirolimus in patients (pts) with relapsed or refractory mantle cell lymphoma (rel/refr MCL) in routine clinical practice
    Dreyling, M.
    Krekeler, G.
    Neuhof, A.
    Woike, M.
    Hess, G.
    Kalanovic, D.
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 156 - 156
  • [27] Evaluation of safety, tolerability and efficacy of temsirolimus in patients (pts) with relapsed or refractory mantle cell lymphoma (rel/refr MCL) in routine clinical practice
    Dreyling, M.
    Hess, G.
    Krekeler, G.
    ANNALS OF ONCOLOGY, 2017, 28
  • [28] Evaluation of safety, tolerability and efficacy of temsirolimus in patients (pts) with relapsed or refractory mantle cell lymphoma (rel/refr MCL) in routine clinical practice
    Dreyling, M.
    Krekeler, G.
    Neuhof, A.
    Woike, M.
    Hess, G.
    Kalanovic, D.
    ANNALS OF ONCOLOGY, 2016, 27
  • [29] Effectiveness and Safety of Ibrutinib in Patients with Mantle Cell Lymphoma (MCL) in Belgian Routine Clinical Practice: 3-Year Follow-up
    Vergote, Vibeke
    Snauwaert, Sylvia
    Saevels, Kirsten
    De Beleyr, Birgit
    Lahaye, Marjolein
    Maes, Ariane
    Demuynck, Hilde
    Debussche, Sarah
    Andre, Marc
    BLOOD, 2022, 140 : 3661 - 3662
  • [30] Evaluation of safety, tolerability and efficacy of Temsirolimus in patients (pts) with relapsed or refractory mantle cell lymphoma (rel/refr MCL) in routine clinical practice
    Dreyling, M.
    Hess, G.
    Woike, M.
    Krekeler, G.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 48 - 48
12345